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Abstract
Objective: The aim of the present study was to systematically review and perform a
meta-analysis of prospective cohort studies exploring the association between
dietary legume consumption and CVD risk, including CHD and stroke.
Design: The PubMed and EMBASE databases were searched up to December
2015. A meta-analysis of the highest v. lowest (reference) category of dietary
legume consumption was performed through random-effects models.
Results: Fourteen studies conducted on eleven cohorts and accounting for a total of
367000 individuals and 18475 cases of CVD (7451 CHD and 6336 stroke cases) were
considered for the analyses. Compared with lower legume consumption, the highest
category of exposure was associated with a decreased risk of 10% in both CVD and
CHD (relative risk=0·90; 95% CI 0·84, 0·97) with no or little evidence of heterogeneity
and no publication bias. Null results were found regarding legume consumption
and stroke risk. No substantial confounding factors were evident in stratified analyses.
Conclusions: Legume consumption was associated with lower risk of CVD.
Legumes’ intrinsic characteristics, because they are often part of an overall healthy
diet, or because they are a substitute for unhealthy sources of protein may







CVD represent the main causes of death globally,
accounting for nearly one-third of all deaths worldwide(1).
Moreover, as life expectancy has improved in both
developed and developing countries, the number of
healthy years lost due to disability has been increasing
consistently(2). Within this scenario, primary prevention of
CVD-related morbidity and mortality represents a major
priority for public health strategies to reduce the burden of
such conditions(3). Lifestyle factors have been considered
main targets to prevent CVD, because they are modifiable
behaviours that could highly affect both the risk and the
prognosis of the disease. A number of healthy dietary
patterns have demonstrated beneficial effects in decreas-
ing the burden of CVD-related risk factors and CVD
incidence and mortality(4,5). Scientific literature suggests
that a diet rich in antioxidants (such as vitamins and
polyphenols), fibre, n-3 fatty acids, MUFA and PUFA may
decrease the risk of the aforementioned conditions(6,7).
Among the potential mechanisms of protection, the
antioxidant and anti-inflammatory action of these com-
pounds may mediate their effects(8,9). From a nutritional
point of view, legumes are a source of some of these
nutrients and bioactive compounds as well as an excellent
source of fibre and vegetable proteins(10,11). Despite not
being associated with decreased risk of CVD themselves,
vegetable proteins may be a valuable alternative to animal
proteins, which on the contrary are associated with
saturated fats and possible adverse outcomes(12).
Meta-analyses of studies on legume consumption and
cardiovascular health demonstrated no association with
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stroke or diabetes(13,14). Legumes considered as part of a
Mediterranean dietary pattern have been associated with a
decreased risk of CVD risk and mortality in studies
evaluating Mediterranean diet as main exposure(15), but a
comprehensive evaluation of their independent role on
such outcomes is lacking. The aim of the present study
was to systematically review and perform a meta-analysis
of prospective cohort studies exploring the association
between dietary legume consumption and CVD risk,
including CHD and stroke.
Participants and methods
Search strategy
We performed a systematic search in PubMed
(http://www.ncbi.nlm.nih.gov/pubmed/) and EMBASE
(http://www.embase.com/) databases of all English-
language studies published up to December 2015. The
search terms used for the study selection were ‘legume’,
‘Mediterranean diet’, ‘soy products’, ‘protein sources’
combined with ‘cardiovascular disease’, ‘coronary heart
disease’ and ‘mortality’. Inclusion criteria were: (i) having a
prospective cohort design; (ii) evaluating the association
between dietary consumption of legumes and CVD; and
(iii) assessing and reporting hazard ratios (HR) and the
corresponding 95% CI for the outcome considered.
Reference lists of included studies were examined for any
additional article not previously identified. If more than
one study was conducted on the same cohort, only the
most comprehensive or most updated was included in the
meta-analysis. The selection process was performed
independently by two authors (G.G. and J.G.).
Data extraction and study quality assessment
Data were abstracted from each identified study by using a
standardized extraction form. The following information
was collected: (i) author name; (ii) year of publication;
(iii) country; (iv) number, sex and age of participants;
(v) HR and 95% CI for all categories of exposure; and
(vi) covariates used in adjustments.
The quality of each study was assessed by applying the
Newcastle–Ottawa Quality Assessment Scale(16). The
instrument consists of three domains indicating the study
quality as follows: selection (4 points), comparability
(2 points) and outcome (3 points), for a total score of 9
points (with 9 points representing the highest quality).
Studies scoring 7–9 points, 3–6 points and 0–3 points were
identified as of high, moderate and low quality, respectively.
Statistical analysis
HR with 95% CI for all categories of exposure were
extracted for the analysis and random-effects models were
used to calculate pooled relative risks (RR) with 95% CI for
the highest v. lowest (reference) category of exposure.
The risk estimate from the most fully adjusted models in
the analysis of the pooled RR was used. When analyses
were presented by sex, stratified results were taken into
account for the pooled analysis. Since most of the studies
considered a composite outcome of CVD incidence or
mortality, when studies presented separate analyses for
the two outcomes, a pooled RR was estimated within the
same study and only secondarily it was included in the
general analysis in order to compare more homogeneous
outcomes. Heterogeneity was assessed by using the Q test
and I 2 statistic. The level of significance for the Q test was
defined as P< 0·10. The I 2 statistic represented the
amount of total variation that could be attributed to het-
erogeneity. I 2 values of ≤25%, ≤50%, ≤75% and >75%
indicated no, small, moderate and significant hetero-
geneity, respectively. A sensitivity analysis by exclusion of
one study at a time was performed to assess the stability of
results and potential sources of heterogeneity. Subgroup
analyses were also performed to check for potential source
of heterogeneity according to geographical area, sample
size, year of publication, study quality, type of exposure
ascertainment method and length of follow-up. Publication
bias was evaluated by a visual investigation of funnel plots
for potential asymmetry. All analyses were performed
with Review Manager (RevMan) software version 5.2 (The
Nordic Cochrane Centre, The Cochrane Collaboration).
Results
Study characteristics
The process of study selection following PRISMA
(Preferred Reporting Items for Systematic Reviews and
Meta-Analyses) guidelines is summarized in Fig. 1. Among
the thirty-four articles obtained after screening on the basis
of title and abstract, twenty studies were excluded after a
full-text examination because they were not relevant for
the research (n 11), did not study CVD as outcome (n 3),
had a study design other than prospective (n 2), reported
insufficient statistics (n 2), were conducted on the
same cohort of another study but had shorter follow-up
(n 1) or considered composite legume and other
foods consumption (n 1). This inclusion strategy resulted in
the final inclusion of fourteen studies(17–30) and thirty-two
data sets eligible to be considered for the quantitative ana-
lysis. Studies included were conducted on eleven cohorts
and accounted for a total of 367 000 individuals and 18 475
cases of CVD, including 7451 CHD and 6336 stroke cases.
Table 1 shows the main characteristics extracted from all
selected studies. The studies were conducted on cohorts
based in the USA(17,18,23,26,28,29), Japan(19,22), Spain(20,24),
Greece(25,27), Finland(21) and Iran(30). The results of quality
assessment yielded a score of 8 or above for all studies
with no substantial limitations or significant weaknesses
across studies. Most of the studies included more than
10 000 individuals and follow-up periods were long
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enough to plausibly observe occurrence of the outcomes
considered in the present review. The amount of dietary
legumes considered as the highest category of exposure
varied across studies in terms of measurements, but in
summary could be roughly estimated as <1 serving/d or
3–4 servings/week.
Legume consumption and CVD risk
All fourteen studies including CVD, CHD and/or stroke
incidence or mortality were considered for the analysis of
the extreme categories of legume consumption and total
CVD. RR with 95% CI of CVD for the highest v. the lowest
legume consumption category were calculated for eight-
een data sets and resulted in a 6% decreased risk of CVD
(RR= 0·94; 95% CI 0·89, 1·00; Fig. 2) with little hetero-
geneity (I2= 40%). Sensitivity analysis led to evidence that
heterogeneity was mainly due to one cohort(28,29) after
exclusion of which heterogeneity was significantly
reduced and risk estimates remained significant.
No publication bias was found for this analysis (see
online supplementary material, Supplementary Fig. 1(d)).
Subgroup analyses were conducted to test the stability of
results or potential confounding factors (Table 2). Overall,
higher legume consumption had a protective effect against
CVD in most subgroups. However, the association was not
significant when analyses included men only, when
studies were conducted in non-Mediterranean countries
and after controlling for dietary variables (Table 2).
A second analysis was conducted including only studies
that specifically considered CVD as the out-
come(17,19,22,24,30). Overall, a decreased risk of 10%
(RR= 0·90; 95% CI 0·84, 0·97; Fig. 2) was observed, with
no evidence of either heterogeneity or publication bias
(see online supplementary material, Supplementary Fig. 1
(c)). Stratified analyses were conditioned by the limited
number of data sets (Table 2). However, no substantial
differences from the primary analysis were found in
studies with a larger sample, longer follow-up and adjus-





on abstract (n 38)
References excluded based
on titles (n 1189)
Studies obtained for abstract
evaluation (n 72)
Studies obtained for full-text
evaluation (n 34)
Studies included in the meta-
analysis (n 14)
References excluded because not
meeting inclusion criteria:
• Not relevant study (n 11)
• Outcome other than CVD (n 3)
• Study design other than prospective (n 2)
• Reported insufficient statistics (n 2)
• Had shorter follow-up (n 1)
• Considered composite legume and
  other food consumption (n 1)
Fig. 1 Flowchart indicating the selection of relevant studies for the systematic review exploring the association between dietary
legume consumption and CVD risk
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NHANES I (USA) M and F 25–74 9632 Incident/fatal CVD 19 CVD: 3680
CHD: 1802
Age, sex, race, history diabetes, PA, education,
alcohol intake, current smoker, energy intake,
BMI, serum TC, SBP, meat and poultry intake,




IWHS (USA) F 55–69 29 017 Fatal CHD 15 Fatal CHD: 739 Age, total energy, saturated fat, polyunsaturated fat,
monounsaturated fat, trans-fat, total fibre, dietary
cholesterol, dietary methionine, alcohol,
smoking, activity level, BMI, history of
hypertension, postmenopausal hormone use,
multivitamin use, vitamin E supplement use,








Age, sex, smoking, alcohol use, BMI, history
hypertension or diabetes mellitus, medication
use for hypercholesterolaemia, education level,
sports, dietary intake of fruits, vegetables, fish,




EPIC (Spain) M and F 29–69 41 078 Incident/fatal CHD 10·4 Total CHD: 609 Education, PA, BMI, smoking status, diabetes,












M and F 40–74 3932 Incident/fatal
CBVD





JACC (Japan) M and F 40–79 59 485 Fatal CVD 13 Fatal CVD: 1207 M,
1036 F
Sex, age, BMI, smoking status, alcohol intake,
hours of walking, hours of sleep, education,
perceived mental stress, cholesterol intake, SFA
intake, n-3 fatty acids intake, Na intake, history





NHS (USA) F 30–55 84 136 Incident/fatal MI 26 MI: 2210
Fatal CHD: 952
Age, time period, energy, cereal fiber, alcohol,
trans-fat, BMI, smoking, menopausal status,





SUN (Spain) M and F 34–43 13 609 Incident CVD 4·9 CVD: 100
Fatal CVD: 8
Age, sex, family history CHD, total energy intake,
PA, smoking, BMI, diabetes at baseline, use of
aspirin, history hypertension, history
hypercholesterolaemia
8
Dilis et al. (2012)(25) EPIC (Greece) M and F 20–86 23 929 Incident/fatal CHD 10 CHD: 636
Fatal CHD: 240
Age, energy, education, height, BMI, PA, smoking
status, blood pressure, intake of alcohol, fruits
and nuts, vegetables, cereals, dairy products,
meat and meat products, fish and seafood,
potatoes, eggs, sweets, non-alcoholic


































(years) No. of cases Adjustments
Study
quality




Age, education, smoking status, BMI, PA,




NHS (USA) F 30–55 84 010 Incident/fatal
CBVD
26 CBVD: 2633 Age, time period, BMI, cigarette smoking, physical
exercise, parental history early MI, menopausal
status, multivitamin use, vitamin E supplement
use, aspirin use at least once per week, total
energy, cereal fibre, alcohol, trans-fat, fruit and




HPFS (USA) M 40–75 43 150 Incident/fatal
CBVD
22 CBVD: 1397 Age, time period, BMI, cigarette smoking, physical
exercise, parental history early MI, multivitamin
use, vitamin E supplement use, aspirin use at
least once per week, total energy, cereal fibre,





ARIC (USA) M and F 45–64 12 066 Incident/fatal CHD 22 CHD: 1147 Age, sex, race, study centre, total energy intake,
smoking, education, SBP, use of
antihypertensive medication, HDL-C, TC, use of
lipid-lowering medication, BMI, WHR, alcohol





ARIC (USA) M and F 45–64 11 601 Incident/fatal
CBVD
22 CBVD: 699 Age, sex, race, study centre, total energy intake,
smoking, education, SBP, use of
antihypertensive medication, HDL-C, TC, use of
lipid-lowering medication, BMI, WHR, alcohol
intake, PA, carbohydrate intake, fibre intake, Mg
intake
9
Nouri et al. (2016)(30) Isfahan Cohort
Study (Iran)
M and F >35 6504 Incident/fatal CVD 6·8 Total CVD: 427 Age, sex, income, marital status, education, job,
ever smoke, leisure-time PA, legume-adjusted





Sudden cardiac death: 54
Angina: 193
NHANES I, First National Health and Nutrition Examination Survey; IWHS, Iowa Women’s Health Study; JPHC, Japan Public Health Center-based; EPIC, European Prospective Investigation into Cancer and Nutrition;
JACCS, Japan Collaborative Cohort Study; NHS, Nurses’ Health Study; SUN, Seguimiento Universidad de Navarra; HPFS, Health Professionals’ Follow-up Study; ARIC, Atherosclerosis Risk in Communities; M, male; F,
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Legume consumption and CHD risk
The analysis relative to CHD risk related to consumption
of legumes comprised twelve data sets derived from eight
studies(17–20,23,24,25,28). Comparison of the highest v. the
lowest legume consumption category showed a similar
risk estimate to the previous analysis considering CVD as
outcome (RR= 0·90; 95% CI 0·84, 0·97; Fig. 2). Little
heterogeneity (I 2= 34%) and no publication bias were
found (see online supplementary material, Supplementary
Fig. 1(a)). Exclusion of one study at the time did not
change the strength of the association. Subgroup analyses
demonstrated stability of results across strata considered,
showing a significant decreased risk of CHD by high
consumption of legumes in all subgroups with the
exception of pooled analysis of studies conducted in the
Mediterranean region.
Legume consumption and stroke risk
Six studies(19,21,22,26,27,29) comprising eight data sets were
considered for the analysis on the highest v. lowest level of
dietary legume intake and stroke risk. The pooled analysis
showed null results with no substantial risk increment or
reduction for higher consumption of legumes (RR= 1·01;
95% CI 0·89, 1·14). The analysis showed moderate
heterogeneity (I 2 = 59%) due to divergent results reported
in two studies(19,29). The stratified analysis (Table 2)
revealed that heterogeneity was attenuated by pooling
studies conducted in non-Mediterranean countries, show-
ing consistently null results, while the study conducted in
Greece(27) reported significant decreased risk of stroke for
higher intake of legumes. Interestingly, also pooling toge-
ther studies reporting adjustment for dietary variables led to
decreased heterogeneity and no significant risk variation.
No evidence of publication bias was found (see online
supplementary material, Supplementary Fig. 1(b)).
Discussion
In the present meta-analysis we found an association
between legume consumption and decreased risk of CVD
incidence or mortality, despite with little heterogeneity
across studies. When the analysis was stratified by type of
CVD outcome, legume consumption was associated with
CHD only and not with stroke risk. The analysis
considering the different outcomes showed that the het-
erogeneity was due to the null results relative to stroke
risk. Previous meta-analyses showed similar results on
stroke(13,14), but to date the current meta-analysis is the
first showing a relationship between legume consumption
and CHD and overall CVD outcomes.
Research on legumes and CVD-related outcomes has
been growing over the last years. The majority of
prospective studies included in our meta-analysis reported
a significant association between legume consumption
and risk of CHD. Legumes have been studied lately due to
a number of potential effects that may provide health
benefits towards CVD risk factors, such as lowering of
blood lipids and improvement in vascular function and
insulin sensitivity(31,32). Legumes are rich in phytosterols,
including soya isoflavones, which have been demon-
strated to be associated with a significant reduction in
serum total cholesterol, TAG and LDL cholesterol, and a
significant increase in HDL cholesterol, in pooled analyses
of randomized controlled trials on soya products
consumption in the general population(33) and patients
with type 2 diabetes mellitus(34). Intakes of these com-
pounds may also protect against atherosclerosis(35).
Legumes, as plant-derived foods, are rich in fibre, which
has been associated with decreased risk of mortality in
prospective cohort studies(36). Dietary fibre is supposed to
ameliorate body metabolism and reduce chronic inflam-
mation by affecting body weight, serum lipid levels, blood
pressure and insulin resistance, as well as to influence
fibrinolysis and coagulation that may be important in the
setting of established atherosclerotic plaques(37). Some
legume families, such as soya, are also dietary sources of
flavonoids, vitamin E and PUFA (α-linolenic acid) which
have demonstrated CVD protection in pooled analyses of
prospective studies, hypothesized to be exerted probably
by their antioxidant effects(38).
Besides the aforementioned potential direct effects of
legumes on cardiovascular health, another potential
mechanism of protection may depend on the fact that
increased consumption of legumes lowers CVD risk simply
by reducing the intake of animal sources of protein that
may be high in SFA(39). Moreover, legume proteins are not
only a source of constructive compounds (such as amino
acids) but they may also exert bioactive effects on various
physiological functions(40). Indeed, legume protein-derived
bioactive peptides have been demonstrated to exert blood
pressure-lowering effects, cholesterol-lowering ability,
antithrombotic and antioxidant activities in the laboratory
setting, suggesting potential benefits that need to be further
investigated in the future(40).
The meta-analyses of the studies providing stratified
analysis by some selected variables showed that a potential
difference between men and women, as well as studies
conducted in Mediterranean and non-Mediterranean coun-
tries, may occur when examining the relationship between
legume consumption and either CVD or CHD risk. A pos-
sible explanation for such difference between men and
women may rely on the fact that men were generally more
likely to be smokers and drink more alcohol(18,20,25), thus
somehow counteracting the potential beneficial effects of
legumes. Another methodological issue may depend on
lower accuracy in reporting dietary patterns among men
than women. It is noteworthy that only a limited number of
studies were included in our sub-analysis by sex, thus lim-
iting the strength of such findings. However, current results
were quite consistent and this hypothesis needs further
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attention in future studies. Regarding the geographical origin
of the cohorts included in the pooled analysis, risk of CHD
was significantly reduced in high legume consumers in
studies conducted in non-Mediterranean countries while
CVD risk was reduced in Mediterranean countries. The
conflicting results may depend on a bias associated with the
relative limited number of studies available for the grouping.
One possible explanation for the lack of significant results in
meta-analyses of studies conducted in Mediterranean coun-
tries could be the impact on cardiovascular health of all
components of the diet typically consumed in these coun-
tries, or at least those included in the individual analyses.
Study
CHD
Bazzano et al. (2001)(17)
Bernstein et al. (2010)(23), F
Buckland et al. (2009)(20), M
Kelemen et al. (2005)(18), F
Kokubo et al. (2007)(19), M
Buckland et al. (2009)(20), F
Kokubo et al. (2007)(19), F
Martinez-Gonzalez et al. (2011)(24)
Nagura et al. (2009)(22)
Dilis et al. (2012)(25), F
Dilis et al. (2012)(25), M
Haring et al. (2014)(23)
Total (95 % CI)
Heterogeneity: I 2 = 34 %
Stroke
Nagura et al. (2009)(22)
Kokubo et al. (2007)(19), F
Bernstein et al. (2012)(26), F
Bernstein et al. (2012)(26), M
Kokubo et al. (2007)(19), M
Mizrahi et al. (2009)(21)
Misirili et al. (2012)(27)
Haring et al. (2015)(29)
Total (95 % CI)
Heterogeneity: I 2 = 59 %
CVD only
CVD any (all studies)
Martinez-Gonzalez et al. (2011)(24)
Bazzano et al. (2001)(17)
Kokubo et al. (2007)(19), F
Kokubo et al. (2007)(19), M
Nouri et al. (2016)(30)
Nagura et al. (2009)(22)
Total (95 % CI)
Heterogeneity: I 2 = 0 %
Total (95 % CI)
Heterogeneity: I 2 = 40 %
0.5 0.7
(RR 95 % CI)
1.0 1.5 2.0
RR    (95 % CI)
0.79  (0.69, 0.90)
0.89  (0.80, 0.99)
1.01  (0.80, 1.28)
0.83  (0.65, 1.06)
0.98  (0.60, 1.60)
0.94  (0.60, 1.47)
0.69  (0.26, 1.83)
0.70  (0.43, 1.14)
0.88  (0.66, 1.17)
0.81  (0.68, 0.96)
0.99  (0.90, 1.09)
1.15  (0.93, 1.42)
0.90  (0.84, 0.97)
0.95  (0.79, 1.14)
0.68  (0.42, 1.10)
1.25  (0.91, 1.72)
0.94  (0.48, 1.84)
0.85  (0.76, 0.95)
1.06  (0.93, 1.21)
1.07  (0.89, 1.29)
1.29  (0.98, 1.70)
1.01  (0.89, 1.14)
0.80  (0.53, 1.21)
0.81  (0.60, 1.09)
0.91  (0.82, 1.01)
0.71  (0.46, 1.10)
1.08  (0.83, 1.41)
0.89  (0.78, 1.02)
0.90  (0.84, 0.97)
0.94 (0.89, 1.00)
Fig. 2 Forest plot of summary relative risk (RR) of CVD for the highest v. lowest (reference) category of legume consumption. The
analysis was stratified by pooling studies exploring as outcome the risk of CHD, stroke, CVD only and any CVD (all studies).
The study-specific RR and 95% CI are represented by the black square and horizontal line, respectively; the area of the black
square is proportional to the specific-study weight to the overall meta-analysis. The centre of the diamond represents the pooled RR
and its width represents the pooled 95% CI
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Indeed, most of these studies did not explore the effects of
dietary legumes alone as the primary variable of interest
towards CVD outcomes, but rather included analyses on
Mediterranean diet and, secondarily, on legumes as a
component of the diet. It is well known that the Mediterra-
nean diet exerts beneficial effects against CVD(41) and thus
the effects of legumes, when considered as part of this
diet, may be attenuated by the overwhelming effect of all
the other components of this dietary pattern. Moreover,
consumption of legumes in non-Mediterranean countries
is generally associated with a significant lower consumption
of red meat, which itself may enhance the lower risk
of CHD(23).
The current review has several strengths. First, all
studies included in the pooled analysis were of high
quality. Indeed, most of them had a large sample and a
long duration of follow-up. Furthermore, all studies pro-
vided adjusted analyses for known risk factors, such as
smoking, alcohol use and physical activity. Finally, results
were not affected by significant heterogeneity and
publication bias. Moreover, we included a number of
subgroup analyses to test for potential confounders as well
as a number of sensitivity analyses to test stability of
results. Besides these strengths, the findings have to be
considered in light of some limitations. First, the nature of
studies included in the meta-analysis was observational,
thus no causal relationship can be assessed. Second,
despite most studies adjusting multivariate analyses by
known confounding factors (smoking, alcohol drinking
and physical activity), residual confounders related to
dietary and lifestyle factors may still exist. Third, methods
of assessment of legume consumption (such as FFQ) may
be affected by recall bias. Finally, the number of data sets
was sufficient to perform a meta-analysis, but the amount
of studies for stratified analyses by sex was relatively low
to draft definite assumptions. Moreover, due to the limited
information provided in the studies regarding the amount
of legumes consumed in each group of exposure, we were
unable to perform a dose–response meta-analysis.
Conclusion
In conclusion, results from the current meta-analysis
showed that high legume consumption is associated with
lower risk of CVD. As legumes have often been reported as
part of an overall healthy diet as well as a substitute for
unhealthy sources of proteins, a number of bioactive natural
compounds may provide the biological plausibility for such
potential beneficial effects. Thus, further efforts should be
made to explore the specific role of legumes in the diet.
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